Skip to main content

Table 5 Univariate analysis comparing ICU survivors and non-survivors

From: Prognosis and ICU outcome of systemic vasculitis

n Deceased (16) Survived (15) p
Age, years 69,5 [29–86] 57 [32–78] 0,04
Sex ratio, m/f 12/4 9/6 0,45
BVAS 24.5 [12.0-52.0] 21.0 [2.0-28.0 ] 0,06
SAPS II 46.5 [21.0-109.0] 35.0 [13.0- 51.0] 0,004
Mechanical Ventilation, n (%) 15 (94%) 10 (67%) 0.08
SOFA 7.0 [2.0-15.0] 3.5 [1.0-10.0] 0.006
VAP, n (%) 10 (62.5%) 10 (66.7%) 0.80
Vasopressive agents, n (%) 13 (81,3%) 5 (33,3%) 0.006
ARDS, n (%) 13 (81,3%) 4 (26,7%) 0.002
RRT, n (%) 13 (81,3%) 5 (33,3%) 0.007
Creatininemia, microm/l 297 [56–1067.0] 76 [32–449] 0.062
  1. Data are presented as median (range) or No/total patients.
  2. BVAS Birmingham Vasculitis Activity Score, SAPSII simplified acute physiology score II, SOFA sequential organ failure assessment, VAP ventilator associated pneumonia, ARDS acute respiratory distress syndrome, RRT renal replacement therapy.